Literature DB >> 15343186

Liver disease in children with primary immunodeficiencies.

Fernanda Rodrigues1, E Graham Davies, Phillip Harrison, James McLauchlin, John Karani, Bernard Portmann, Alison Jones, Paul Veys, Giorgina Mieli-Vergani, Nedim Hadzić.   

Abstract

OBJECTIVE: To investigate clinical features and to establish optimal management in children with primary immunodeficiency (PID) and liver disease. Study design A retrospective analysis of medical records of 147 children with PID who presented with abnormal liver tests to a tertiary center.
RESULTS: Clinical evidence of liver disease was documented in 35 (23.8%) patients. Of these, 22 (63%) had hepatomegaly and 14 (40%) had splenomegaly. Sclerosing cholangitis (SC) was diagnosed in 21 children (60%), based on radiological and histological criteria; 4 patients with SC on cholangiography had no biliary changes in the liver biopsy. Ultrasonography demonstrated a dilated biliary system in 14 (67%) children with SC. Of 27 children investigated for Cryptosporidium parvum (CSP), 12 (44%) were positive, including 9 of 12 with SC. Overall, 7 (20%) patients died, including 3 boys with disseminated recurrent CSP infection after successful liver transplantation (LT). Temporary deterioration of liver injury was observed in 2 CSP-positive boys with CD40 ligand deficiency (CD40LD) who were undergoing nonmyeloablative hematopoietic stem cell transplantation (HSCT). Successive liver and HSCT was curative in 1 patient with CD40LD and end-stage liver disease.
CONCLUSION: SC is the most common hepatic complication of PID. Mild liver involvement could be arrested by early nonmyeloablative HSCT, whereas advanced disease may warrant combined liver and HSCT.

Entities:  

Mesh:

Year:  2004        PMID: 15343186     DOI: 10.1016/j.jpeds.2004.05.037

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

Review 1.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

2.  Sclerosing cholangitis and combination antifungal therapy for PNP deficiency patients.

Authors:  Luis Ignacio Gonzalez-Granado
Journal:  Eur J Pediatr       Date:  2009-09-15       Impact factor: 3.183

3.  Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype.

Authors:  M Moncada-Vélez; A Vélez-Ortega; J Orrego; I Santisteban; J Jagadeesh; M Olivares; N Olaya; M Hershfield; F Candotti; J Franco
Journal:  Scand J Immunol       Date:  2011-11       Impact factor: 3.487

Review 4.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

5.  X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene.

Authors:  Tian-Jiao Wang; Li-Fang Wu; Junguo Chen; Wen Zhu; Hua Wang; Xiao-Lin Liu; Yi-Qun Teng
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 6.  Current management of primary sclerosing cholangitis in pediatric patients.

Authors:  Samar H Ibrahim; Keith D Lindor
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

7.  Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.

Authors:  Alexandra F Freeman; Nada Yazigi; Nirali N Shah; David E Kleiner; Mark Parta; Prescott Atkinson; Theo Heller; Steven M Holland; Stuart S Kaufman; Khalid M Khan; Dennis D Hickstein
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

Review 8.  Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.

Authors:  P Wood; S Stanworth; J Burton; A Jones; D G Peckham; T Green; C Hyde; H Chapel
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 9.  Clinical immunology review series: an approach to the patient with recurrent infections in childhood.

Authors:  M A Slatter; A R Gennery
Journal:  Clin Exp Immunol       Date:  2008-03-28       Impact factor: 4.330

10.  Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.

Authors:  C Ward; M Lucas; J Piris; J Collier; H Chapel
Journal:  Clin Exp Immunol       Date:  2008-07-18       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.